![]() Verve Therapeutics closed a follow-on public offering, raising EUR 241 million.Disc Medicine and Gemini Therapeutics announced a merger agreement to create a NASDAQ-listed, clinical-stage biopharma company.Later in the year F2G announced a EUR 65 million financing. F2G Ltd entered into a collaboration with Shionogi & Co Ltd with an upfront payment of EUR 93 million and additional milestone payments of up to EUR 354 million.Rondo Therapeutics closed a EUR 62 million series A financing.closed a EUR 43 million series A financing. We deployed EUR 403 million during the year. Companies can also draw on our extensive network, as well as our commercial and scientific expertise within the life sciences.ĭuring 2022, Venture Investments executed 38 investments. and currently has Fellows working in twelve cities: Baltimore, Cincinnati, Cleveland, Columbus, Detroit, Las Vegas, Miami, New Orleans, Philadelphia, Providence, San Antonio, and St. Every Fellow’s experience is unique, but the adventure of starting an exciting job and moving to a new city feels so much less daunting when a community of Fellows is there to offer support and work. We work actively with the companies we invest in by serving on the Boards of Directors. Venture for America (VFA) Fellowships provide for two years of paid work experience with start-up or early stage companies in emerging cities across the U.S. Venture For America has allowed me to grow so much as a young professional and given me the confidence to see myself a future startup leader. In medtech and digital health, we invest in commercial stage companies. Within biotech we primarily invest in companies with late preclinical or clinical stage compounds. ![]() ![]() We invest in biotechnology, medical technology and digital health companies. With colleagues on the ground in Copenhagen, London, Singapore, San Francisco and Boston, we are well positioned in the major global life science hubs and can quickly respond to new and exciting investment opportunities wherever they emerge. Learn More You love exploring your passions, making new friends, and discovering the world. This funding structure enables us to take a long-term perspective. We invest in both private and public companies from an open evergreen fund. We focus on generating strong financial returns from our portfolio of venture companies. We strive to invest in companies that develop innovative drugs, medical devices and diagnostics. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |